NWM
BMY icon

Northcape Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Northcape Wealth Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$717K Buy
11,814
+11
+0.1% +$641 0.2% 85
2025
Q4 		$637K Sell
11,803
-501
-4% -$24.1K 0.18% 89
2025
Q3 		$555K Sell
12,304
-841
-6% -$39.3K 0.16% 97
2025
Q2 		$609K Sell
13,145
-85
-0.6% -$4.17K 0.19% 91
2025
Q1 		$807K Buy
13,230
+3,293
+33% +$192K 0.26% 75
2024
Q4 		$562K Buy
9,937
+3,860
+64% +$216K 0.18% 92
2024
Q3 		$314K Sell
6,077
-649
-10% -$30.4K 0.1% 112
2024
Q2 		$279K Buy
6,726
+254
+4% +$11.4K 0.1% 118
2024
Q1 		$351K Sell
6,472
-212
-3% -$10.8K 0.13% 102
2023
Q4 		$343K Buy
6,684
+402
+6% +$21.1K 0.12% 113
2023
Q3 		$365K Buy
6,282
+3,045
+94% +$187K 0.14% 110
2023
Q2 		$207K Buy
3,237
+220
+7% +$14.8K 0.07% 144
2023
Q1 		$209K Buy
+3,017
New +$213K 0.08% 145
2022
Q4 		– Sell
-5,567
Closed -$396K – 80
2022
Q3 		$396K Buy
5,567
+2,350
+73% +$170K 0.14% 103
2022
Q2 		$248K Sell
3,217
-2,080
-39% -$158K 0.09% 111
2022
Q1 		$387K Buy
5,297
+2,080
+65% +$140K 0.11% 113
2021
Q4 		$201K Buy
+3,217
New +$189K 0.07% 131

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northcape Wealth Management's BMY Position: Q1 2026 in Review

Northcape Wealth Management increased its Bristol-Myers Squibb (BMY) stake by 0.09% in Q1 2026, buying an estimated $641 and bringing the position to 11,814 shares worth $717K. The position accounts for 0.2% of the portfolio, ranked #85.

Northcape Wealth Management first reported a position in BMY in Q4 2021 and has held it in 17 quarters since. The position peaked at $807K in Q1 2025. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Northcape Wealth Management held 11,814 shares of Bristol-Myers Squibb worth $717K as of Q1 2026.
  • Northcape Wealth Management bought 11 Bristol-Myers Squibb shares in Q1 2026, an estimated $641.
  • Bristol-Myers Squibb made up 0.2% of Northcape Wealth Management's portfolio in Q1 2026, its #85 holding.
  • Northcape Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 17 quarters since.
  • Northcape Wealth Management's Bristol-Myers Squibb position peaked at $807K in Q1 2025.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Northcape Wealth Management's 13F filing for Q1 2026, filed 1 May 2026.